Profiel
Tausif Butt currently works at Navigator Medicines, Inc., as Chief Executive Officer from 2025.
Mr. Butt also formerly worked at AstraZeneca PLC, as Senior Vice President-Latin America from 2019 to 2021, ChemoCentryx, Inc., as Chief Operating Officer & Executive Vice President from 2021 to 2022, and Idorsia Pharmaceuticals US, Inc., as President & General Manager.
Mr. Butt received his graduate degree from Imperial College London and undergraduate degree from the University of Brighton.
Actieve functies van Tausif Butt
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Tausif Butt
| Bedrijven | Functie | Einde |
|---|---|---|
| CHEMOCENTRYX, INC. | Operationeel Directeur | 20-10-2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2021 |
Idorsia Pharmaceuticals US, Inc. | President | - |
Opleiding van Tausif Butt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Brighton
University of Brighton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idorsia Pharmaceuticals US, Inc. | Health Technology |
















